BlackRock Fund Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$78M	Buy	2,704,309 +150,022	+6%	+$3.97M	0.01%	1388
2016 Q3	$81.3M	Buy	2,554,287 +214,275	+9%	+$7.26M	0.02%	1235
2016 Q2	$76M	Sell	2,340,012 -1,209,066	-34%	-$40.5M	0.02%	1200
2016 Q1	$99.2M	Buy	3,549,078 +349,519	+11%	+$7.62M	0.02%	962
2015 Q4	$114M	Sell	3,199,559 -191,052	-6%	-$6.73M	0.03%	858
2015 Q3	$112M	Buy	3,390,611 +183,527	+6%	+$7.64M	0.03%	818
2015 Q2	$134M	Sell	3,207,084 -69,296	-2%	-$2.68M	0.03%	763
2015 Q1	$107M	Buy	3,276,380 +84,595	+3%	+$2.91M	0.03%	940
2014 Q4	$101M	Buy	3,191,785 +264,873	+9%	+$7.51M	0.03%	940
2014 Q3	$72.5M	Sell	2,926,912 -9,031	-0.3%	-$211K	0.02%	1093
2014 Q2	$66.3M	Sell	2,935,943 -131,727	-4%	-$2.75M	0.02%	1210
2014 Q1	$74.6M	Buy	3,067,670 +276,101	+10%	+$6.98M	0.02%	1086
2013 Q4	$69.8M	Sell	2,791,569 -1,133	-0%	-$26.7K	0.02%	1142
2013 Q3	$76.7M	Buy	2,792,702 +371,913	+15%	+$7.77M	0.03%	970
2013 Q2	$43.9M	Buy	+2,420,789	New	+$33.3M	0.02%	1313